BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 17, 2005
View Archived Issues
Amyloidosis and renal disease progression
Read More
Q3 progress at Incyte
Read More
CombiMatrix and Novavax collaborate on technology for vaccine production
Read More
Financing at AM-Pharma to advance programs into phase II
Read More
Boehringer Ingelheim and Biolipox partner on drugs for pain and inflammation
Read More
Tolvaptan for autosomal dominant polycystic kidney disease
Read More
Endogenous stem cell activation for the treatment of Parkinson's
Read More
Treating glucose-deprived neurons ameliorates cognitive deficits and oxidative damage
Read More
Levosimendan reported effective in the treatment of ADHF
Read More
Synairgen begins phase I trial of IFN-beta to reduce asthma exacerbations
Read More
tgAAC-09 begins phase II study in South Africa
Read More
New approaches to pandemic influenza vaccine development
Read More
Phase I/II trial evaluates MGCD-0103 and azacitidine for MDS and AML
Read More
Welichem begins new initiatives with Chinese partners
Read More
Spectrum reports product development highlights of third quarter
Read More
New selective inhibitor of enterovirus replication for myocarditis
Read More
Antitumor effects of antibody-drug conjugate targeting glycoprotein NMB
Read More
NLNQ-1: a novel hypoxia-selective cytotoxin and radiosensitizer
Read More
EP4 agonism as a treatment for diabetic nephropathy
Read More
Ghrelin reverses endothelial function in patients with metabolic syndrome
Read More
New p38 MAPK inhibitor shows joint-protective effects in rat adjuvant-induced arthritis
Read More
Altana withdraws Daxas MAA
Read More
Novel FXR activator shows promise in the treatment of hepatic fibrosis
Read More
Recent patents describe novel anti-hepatitis agents
Read More
New CETP inhibitors disclosed in recent Merck & Co. patent
Read More
New treatments for neuropsychiatric disorders claimed in recent patent literature
Read More
Update on SCH-503034 in the treatment of hepatitis C
Read More